학술논문

Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients.
Document Type
Article
Source
Journal of Neurology. Mar2016, Vol. 263 Issue 3, p524-530. 7p. 1 Black and White Photograph, 1 Diagram, 1 Chart, 1 Graph.
Subject
*GLIOBLASTOMA multiforme
*MAGNETIC resonance imaging
*ANGIOTENSIN analysis
*PATIENT management
*CARDIOVASCULAR disease diagnosis
*HYPERTENSION
*THERAPEUTICS
*PATIENTS
Language
ISSN
0340-5354
Abstract
Glioblastoma patients often require chronic administration of steroids due to peri-tumoral edema. Preliminary studies showed that treatment with Angiotensin-II Receptor Blockers (ARBs) for high blood pressure might be associated with reduced peri-tumoral edema. In this study, we aim to radiologically assess the effect of ARBs on peri-tumoral edema. We conducted a cross-sectional survey on patients with newly diagnosed GBM. Patients treated with ARBs for high blood pressure were paired to non ARB-treated patients based on similar age, tumor location and tumor size. Patients taking steroids at the time of pre-operative Magnetic Resonance Imaging were excluded from the study. In each pair of patients, we compared the volumes of peri-tumoral hyper T2-Fluid Attenuated Inversion Recovery (FLAIR) signal and the Apparent Diffusion Coefficient (ADC) in the same area. Eleven (11) ARB-treated patients were selected and paired to 11 non ARB-treated controls. Volumes of peri-tumoral hyper T2-FLAIR signal were significantly lower in the ARB-treated group than in the non ARB-treated group ( p = 0.02). Additionally, peri-tumoral ADCs were also significantly lower in the treated group ( p = 0.02), suggesting that the peri-tumoral area in this group had less edematous features. These results suggest that ARBs may reduce the volume of peri-tumoral hyper T2-FLAIR signal by decreasing edema. [ABSTRACT FROM AUTHOR]